Metabolic Effects of Cocaine
Not Applicable
Completed
- Conditions
- Cocaine Dependence
- Registration Number
- NCT00451230
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The goal of this this study is to elucidate the role of the HPA axis in the pathophysiology of cocaine dependence
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- Individuals with DSM IV diagnosis of cocaine dependence, medically healthy
Exclusion Criteria
- Other than cocaine dependence DSM-IV axis I diagnosis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link HPA axis dysregulation to cocaine dependence pathophysiology?
How do HPA axis modulators compare to standard-of-care treatments for cocaine addiction?
Which biomarkers correlate with HPA axis activity in cocaine-dependent patients?
What adverse events are associated with HPA axis-targeted therapies for substance use disorders?
Are there combination approaches involving HPA axis regulation and existing addiction treatments?
Trial Locations
- Locations (1)
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States
Massachusetts General Hospital🇺🇸Boston, Massachusetts, United States